The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. - Wikidata - awgldk - TriplyDB

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

http://www.wikidata.org/entity/Q34781878

about

Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children CCR5 monoclonal antibodies for HIV-1 therapy Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.Bioinformatic analysis of HIV-1 entry and pathogenesis.Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage Appreciating HIV type 1 diversity: subtype differences in Env.Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo The variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an HIV-1 strain.High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C viruses Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.Clinical use of CCR5 inhibitors in HIV and beyond Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.Diversity of HIV type 1 envelope (V3-V5) sequence in HIV type 1-infected Indian children.UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins.

P2860

Q21261525-A9A1C135-F9B3-4BFC-8920-D03DB4BD4AEF Q22242739-50B4EB0E-9C24-451A-A1E8-DE9E680262C2 Q24612992-B99514F6-A806-4B89-83B1-001C609493CB Q24815687-360887D5-29F7-4117-ACAF-28BBFB5050E8 Q27693321-2B770C05-5F12-457E-8E7A-8440FAF0D9D6 Q28365077-897A69E8-DB91-43B2-8AC2-6B3F417F42B8 Q28469177-B855F901-FF12-4E62-BC50-5BD0D7A183E9 Q30375834-08E2538C-5D91-4C71-AD8C-CE32C322F183 Q33565651-C2359D3F-265D-4269-9329-5E4DC25EAAE3 Q33576606-286DAA69-0ADE-4609-85E5-D3A01B133288 Q33711710-46ABA6EC-6EAF-4AD4-BA29-EEEE139C27F2 Q33736978-16A25F56-3ED6-4CAC-97CC-DC1E39D7BA5C Q33749206-3999C544-9546-410D-86B1-EB6F2D8A1954 Q33780524-22744010-1E27-4A7F-B51C-3458F7CD18B8 Q33793066-B4B0E3DF-248E-46EB-B9D1-6332BEEF05A8 Q33843345-ECF5626B-A101-4087-B750-98D94B79698E Q34100228-4288A86A-26C9-4955-BB43-BE70FF79812B Q34243467-54C306E8-6273-409B-AEC7-5F25B3F16BCA Q34269253-E27E8F02-82EC-4970-BC5D-7B6B99639899 Q34400487-43AFB9B3-45F7-4B37-B7B3-382791DC52B8 Q34425169-FEE755F1-5F99-46FF-AA6A-0E8C5032D67E Q34611466-D5784B85-0C8E-430D-8148-674A934B1C56 Q34647858-493E9B90-4EFA-4FC2-ACBB-01F31ABA16D5 Q34792976-57024477-251C-4528-A5B4-F2EF1808A511 Q35018145-8CACF204-8827-4E63-BB6B-6266CCDA4B1C Q35133895-7CDF14D3-7F8D-4B64-AC8A-9F8A2B7D2AE0 Q35140032-3BF2F574-102C-414D-9CED-40B0CBCF43D2 Q35161426-A1CDDBAD-C862-45BF-A0BE-299F2CD97B7D Q35192937-920BD592-9F12-4D33-91C8-11B8B4D4AF1A Q35386184-FCAAED3F-09F8-43B0-8158-0E680311C90E Q35743210-C16C928B-CE21-4432-9F5E-D02CA3CE2E7F Q35904487-1E9C92C3-63CB-4FDF-B269-978A850387D2 Q35943810-F3D95E84-F458-4A55-8511-891632DC3FEC Q35947561-AC5BACE3-3C7B-42E4-BFB5-1ED5EB61D11B Q35947621-6A10BAE8-F2B0-4374-8790-FA80151D5DFE Q35964202-973B3AC0-1549-4747-9349-AE93749D3EFB Q36050101-C70938D5-552A-48D5-8615-8DDCB4545D90 Q36334067-21A080EC-A303-419F-99AB-72282357C14E Q36382002-877DD746-2409-4316-9079-E1A099517566 Q36424523-CFB58525-D933-4D1C-BAB6-521AF0AD000D

P2860

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

http://www.wikidata.org/entity/Q34781878

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@ast

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@en

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@nl

type

label

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@ast

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@en

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@nl

prefLabel

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@ast

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@en

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@nl

P1433

Q34781878-D893C0C9-D225-4C0E-B2E1-2A02D9E2A9FC

P1476

Q34781878-385DC9A8-B24C-4B68-B79E-CF729378B191

P2093

Q34781878-0C76B200-552C-4457-9872-FA55DB656054

Q34781878-17971786-46F4-4FA1-ADD0-99F07855C4AF

Q34781878-3085A6F4-7363-45F4-9392-E8D63CA61491

Q34781878-3920A19C-BCC5-4FDB-A270-C62ABA7AD2A2

Q34781878-5EA9DE09-54B9-4E3A-A710-9AB24B231E27

Q34781878-61805AD7-477A-49F4-BC73-06ECE3431F7F

Q34781878-9D14A7C6-1C1D-4E95-899E-BC089B36F76D

P2860

Q34781878-042F590C-1B9A-424D-8D31-B572ABFC96A6

Q34781878-049511BA-829D-45DA-AA57-BA6683EF5084

Q34781878-052FFC8C-3349-4129-8257-5EA6C46C29D3

Q34781878-0C68E453-F19D-4DCE-B098-FD4FB2FA10AE

Q34781878-1C3E4693-3D65-417E-9785-F638DFE954D5

Q34781878-2383B79A-4619-46DB-949C-87785F00BD06

Q34781878-2D8D4E83-FFDC-4FD7-95B6-94C079E2A35A

Q34781878-3773A4FD-9DA6-426E-883C-306B38627A7F

Q34781878-43505F41-3E13-4587-9A91-3E96A1B7B967

Q34781878-43D41A4D-DF22-4632-A105-48241B20E1B8

P304

Q34781878-7C893CF5-2488-4CA3-BF50-D0B1E986B450

P31

Q34781878-389D5622-3143-494A-BE77-02E628A54E36

P356

Q34781878-BD99FEDB-4E67-4C6E-A179-10D7A4FE0135

P407

Q34781878-27B812D0-74C8-4EBF-81FE-6DDEEC587077

P433

Q34781878-9ABC2538-D684-497F-8217-58053F32C01B

P478

Q34781878-6C7AA436-E0D2-411E-934E-FC68CA1F9B3B

P50

Q34781878-9304CDD0-2C29-476D-A162-552C9763B9F0

Q34781878-FF727FD5-DDE8-46E3-8DE9-3DC78BB62E1B

P577

Q34781878-42EF9461-00ED-4456-90F7-18AAAFE6646E

P5875

Q34781878-DF402FB3-85B9-4A31-9474-DFB9DF5CFFA6

P698

Q34781878-76307DC5-ECDC-4460-BAD3-3BDF3E485FAA

P932

Q34781878-3F44E45D-4395-4EB1-ABFF-B70E57EB0F42

P356

JVI.77.7.4449-4456.2003

P1433

Journal of Virology

P1476

The CCR5 and CXCR4 coreceptors ...... imary isolates from subtype C.

@en

P2093

Dragana Orlovic

http://www.w3.org/2001/XMLSchema#string

Jabulani Nhlapo

http://www.w3.org/2001/XMLSchema#string

John P Moore

http://www.w3.org/2001/XMLSchema#string

Mia Coetzer

http://www.w3.org/2001/XMLSchema#string

Thomas Ketas

http://www.w3.org/2001/XMLSchema#string

Tonie Cilliers

http://www.w3.org/2001/XMLSchema#string

William C Olson

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning of new receptors used by simian and human immunodeficiency viruses

Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection

New targets for inhibitors of HIV-1 replication

Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

P304

4449-4456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.7.4449-4456.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Alexandra Trkola

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10859271

http://www.w3.org/2001/XMLSchema#string

P698

12634405

http://www.w3.org/2001/XMLSchema#string

P932

150635

http://www.w3.org/2001/XMLSchema#string